4 months Centessa Pharmaceuticals plc (NASDAQ:CNTA) CEO Saurabh Saha Sells 2,592 Shares MarketBeat

   X     

4 months Ionis Pharmaceuticals: Catalysts Due In 2025/2026 Are Extremely Compelling Seeking Alpha

   X     

4 months Regeneron Pharmaceuticals (NASDAQ:REGN) Receives “Neutral” Rating from Cantor Fitzgerald MarketBeat

   X     

4 months Alnylam Pharmaceuticals (ALNY) is a Great Momentum Stock: Should You Buy? Zacks

   X     

4 months ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up – Here’s What Happened MarketBeat

   X     

4 months Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Lowered to $1,080.00 at Barclays MarketBeat

   X     

4 months Kiniksa Pharmaceuticals (KNSA) Scheduled to Post Quarterly Earnings on Tuesday MarketBeat

   X     

4 months Oppenheimer Cuts Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target to $350.00 MarketBeat

   X     

4 months Amylyx Pharmaceuticals (NASDAQ:AMLX) Upgraded at Bank of America MarketBeat

   X     

4 months The Zacks Analyst Blog Highlights Novo Nordisk, Novartis, Pfizer, Regeneron Pharmaceuticals and Biogen Zacks

   X     

4 months Sequoia Financial Advisors LLC Raises Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) MarketBeat

   X     

4 months Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Cut to $1,050.00 by Analysts at Wells Fargo & Company MarketBeat

   X     

4 months BioCryst Pharmaceuticals (NASDAQ:BCRX) Stock Price Up 4.7% – Here’s What Happened MarketBeat

   X     

4 months Crinetics Pharmaceuticals (NASDAQ:CRNX) Hits New 1-Year High – Here’s What Happened MarketBeat

   X     

4 months Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Down 1.5% – Here’s What Happened MarketBeat

   X     

4 months Regeneron Pharmaceuticals (NASDAQ:REGN) Earns “Outperform” Rating from Royal Bank of Canada MarketBeat

   X     

4 months Truist Financial Raises ANI Pharmaceuticals (NASDAQ:ANIP) Price Target to $62.00 MarketBeat

   X     

4 months AstraZeneca Receives CHMP’s Approval for Wainzua in Europe Zacks

   X     

4 months Corvus Pharmaceuticals (NASDAQ:CRVS) Sets New 52-Week High – Should You Buy? MarketBeat

   X     

4 months BMY or VRTX: Which Is the Better Value Stock Right Now? Zacks

   X     

4 months Do Options Traders Know Something About Acadia (ACAD) Stock We Don’t? Zacks

   X     

4 months Madrigal Pharmaceuticals (NASDAQ:MDGL) Earns Buy Rating from HC Wainwright MarketBeat

   X     

4 months Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Receives Consensus Rating of “Moderate Buy” from Analysts MarketBeat

   X     

4 months Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Given Average Rating of “Moderate Buy” by Brokerages MarketBeat

   X     

4 months Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Price Passes Below Two Hundred Day Moving Average – Here’s What Happened MarketBeat

   X     

4 months Creative Planning Purchases 2,178 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) MarketBeat

   X     

4 months ARS Pharmaceuticals (NASDAQ:SPRY) Stock Price Up 4.3% – Should You Buy? MarketBeat

   X     

4 months Why Vertex Pharmaceuticals (VRTX) Dipped More Than Broader Market Today Zacks

   X     

4 months Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 5.3% – Here’s What Happened MarketBeat

   X     

4 months Arrowhead Pharmaceuticals (NASDAQ:ARWR) Stock Price Down 6.4% – Here’s Why MarketBeat

   X     

4 months Recursion Pharmaceuticals (NASDAQ:RXRX) Stock Price Down 3.6% – Should You Sell? MarketBeat

   X     

4 months Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Price Down 4.8% – What’s Next? MarketBeat

   X     

4 months Merck Stock Down More Than 14% in 6 Months: Buy, Sell or Hold? Zacks

   X     

4 months Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Receives Consensus Rating of “Moderate Buy” from Analysts MarketBeat

   X     

4 months Longboard Pharmaceuticals (NASDAQ:LBPH) Sees Unusually-High Trading Volume – Should You Buy? MarketBeat

   X     

4 months Verrica Pharmaceuticals (NASDAQ:VRCA) Given New $10.00 Price Target at TD Cowen MarketBeat

   X     

4 months 50,500 Shares in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Purchased by Toth Financial Advisory Corp MarketBeat

   X     

4 months Terns Pharmaceuticals: Another Potential GLP-1 Entrant Seeking Alpha

   X     

4 months Supernus Pharmaceuticals (NASDAQ:SUPN) Reaches New 12-Month High – Time to Buy? MarketBeat

   X     

4 months TD Cowen Boosts Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $371.00 MarketBeat

   X     

4 months Ligand Pharmaceuticals (NASDAQ:LGND) PT Raised to $157.00 MarketBeat

   X     

4 months Avadel Pharmaceuticals’ (AVDL) Buy Rating Reiterated at HC Wainwright MarketBeat

   X     

4 months Vertex Pharmaceuticals (NASDAQ:VRTX) Given Buy Rating at HC Wainwright MarketBeat

   X     

4 months Guggenheim Initiates Coverage on Rhythm Pharmaceuticals (NASDAQ:RYTM) MarketBeat

   X     

4 months Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? Zacks

   X     

4 months Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Holdings Boosted by Raymond James & Associates MarketBeat

   X     

4 months Vertex Pharmaceuticals: A Long-Term Growth Monster Seeking Alpha

   X     

4 months Q3 EPS Estimates for FENC Boosted by Capital One Financial MarketBeat

   X     

4 months Capital One Financial Estimates TSE:FRX Q3 Earnings MarketBeat

   X     

4 months Chicago Capital LLC Has $54.63 Million Position in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) MarketBeat

   X